Skip to content
Huberman LabHuberman Lab

How to Optimize Cognitive Function & Brain Health | Dr. Mark D'Esposito

In this episode, my guest is Dr. Mark D'Esposito, M.D., a neurologist and professor of neuroscience and psychology at the University of California, Berkeley. We discuss the brain mechanisms underlying cognition and the forms of memory required for focus, productivity, planning and achieving goals, and learning. We discuss neurochemicals such as dopamine and acetylcholine and how they can be leveraged to improve cognitive functioning. We also discuss concussion, traumatic brain injury (TBI), Alzheimer's, and Parkinson's disease, and ways to restore or slow cognitive decline by using pharmacologic, lifestyle and behavioral protocols. This episode provides a modern understanding of cognition and memory and actionable tools to optimize brain health and function. *Thank you to our sponsors* AG1: https://drinkag1.com/huberman Maui Nui: https://mauinuivenison.com/huberman Joovv: https://joovv.com/huberman Eight Sleep: https://eightsleep.com/huberman LMNT: https://drinklmnt.com/hubmerman Momentous: https://livemomentous.com/huberman *Dr. Mark D'Esposito* Academic profile: https://bit.ly/49wwPMo Lab website: https://bit.ly/3I4Sxev BrainHealth project: https://bit.ly/3SEiZ3w Publications: https://bit.ly/3T4AH1J X: https://twitter.com/mtdespo *Journal Articles* Cognitive and attentional mechanisms in delay of gratification: https://bit.ly/49zpHPL Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control: https://bit.ly/3UdfWBP Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey: https://bit.ly/4bBqMI9 Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19”: https://bit.ly/42IuviW Estrogen Shapes Dopamine-Dependent Cognitive Processes: Implications for Women's Health: https://bit.ly/42G4xwF Ongoing dynamics in large-scale functional connectivity predict perception: https://bit.ly/3SMFT92 *Other Resources* BrainHQ: https://bit.ly/3I6y5d6 The BrainHealth Project: https://bit.ly/3I591Dm Neuroscouting: https://bit.ly/42IpZB8 *Huberman Lab Episodes Mentioned* Nicotine's Effects on the Brain & Body & How to Quit Smoking or Vaping: https://go.hubermanlab.com/GpyRhoQTYT Tools to Enhance Working Memory & Attention: https://go.hubermanlab.com/s7LQP1bsYT Dr. Matthew Walker: The Science & Practice of Perfecting Your Sleep: https://go.hubermanlab.com/psVAPrDqYT How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks: https://go.hubermanlab.com/ggl7TvJuYT *People Mentioned* Brian Levine: Professor Dept. of Psychology, University of Toronto: https://bit.ly/49h05qz Matthew Walker: Professor of Neuroscience & Psychology, UC Berkeley: https://bit.ly/3UK2Ags Michael Merzenich: Professor Emeritus - Neuroscience, USCF: https://bit.ly/3T4rSoD David Hubel and Torsten Wiesel: Nobel Prize (1981): https://bit.ly/3T6SPYQ Emily Jacobs: Associate Professor of Psychology, UC Santa Barbara: https://bit.ly/3T0AaOa Art Kramer: Professor Emeritus, University of Illinois Urbana-Champaign: https://bit.ly/48l4982 Eddie Chang: Professor of Neurological Surgery, UCSF: https://bit.ly/3SLsjmd Karl Deisseroth: Professor and Psychiatrist, Stanford: https://stanford.io/49BQmuG Sepideh Sadaghiani: Associate Professor of Psychology, University of Illinois Urbana-Champaign: https://bit.ly/48CagoF *Timestamps* 00:00:00 Dr. Mark D’Esposito 00:02:08 Sponsors: Maui Nui, Joovv & Eight Sleep 00:06:23 Brain & Frontal Lobes, Prefrontal Cortex, Executive Function 00:10:31 Frontal Lobe Development, Children 00:14:12 Rules, Context & Impulse Control; Learning & Goals 00:21:45 Focus, Improving Executive Function 00:26:04 Connections & Top-Down Signals 00:29:02 Sponsor: AG1 00:30:29 Frontal Lobe Injury; Emotional Regulation 00:37:26 Smartphones, Social Media 00:44:37 Working Memory, Dopamine 00:52:59 Sponsor: LMNT 00:54:22 Dopamine Levels & Working Memory, Cognitive Tasks, Genetics 01:00:03 Bromocriptine & Working Memory, Dopamine 01:06:21 Guanfacine, Neurotransmitter Levels, Pupil Dilation & Biomarker Tests 01:12:46 Bromocriptine, Olympics; Pharmacology & Cognitive Function, Adderall 01:19:27 Concussion, Traumatic Brain Injury (TBI) 01:25:22 Sleep, TBI, Concussion & Executive Function; BrainHQ 01:31:57 Aging & Frontal Executive System; Brain Health 01:39:26 Tools: Brain Health & Boosting Executive Function, Books 01:47:26 Alzheimer’s Disease, Genetics, Pharmacology 01:51:48 Parkinson’s Disease, L-Dopa; Coping with Alzheimer’s; Nicotine 01:58:37 Estrogen & Dopamine, Cognition; Tool: Physical Exercise 02:04:43 Tool: Mindfulness Meditation & Executive Function 02:10:31 Brain Networks; Modularity 02:17:08 Modularity, Brain Indices 02:22:53 Psilocybin; Transcranial Magnetic Stimulation 02:30:16 Zero-Cost Support, Spotify & Apple Reviews, YouTube Feedback, Sponsors, Momentous, Social Media, Neural Network Newsletter #HubermanLab Disclaimer: https://www.hubermanlab.com/disclaimer

Andrew HubermanhostDr. Mark D'Espositoguest
Feb 19, 20242h 32mWatch on YouTube ↗

CHAPTERS

  1. 0:00 – 13:00

    Intro to Executive Function, Memory, and Today’s Goals

    Huberman introduces Mark D’Esposito, highlighting his pioneering work in human brain imaging, executive function, and memory, and sets the agenda: neural circuits of cognition, the role of dopamine and working memory, and practical ways to optimize and restore cognitive function in health and disease.

    • Executive function is central to daily life: planning, context-appropriate behavior, and strategy.
    • Memory and executive function are tightly intertwined in real-world behavior.
    • Episode will cover healthy optimization and restoration after conditions like TBI, Alzheimer’s, Parkinson’s, and ADHD.
    • Sponsors and podcast context (separate from Huberman’s Stanford role) are briefly described.
  2. 13:00 – 26:20

    Frontal Lobes 101: The Brain’s CEO and Its Development

    D’Esposito defines the frontal lobes and prefrontal cortex as the highest-level cortical systems, responsible for cognitive control and executive function. They discuss symptoms of frontal dysfunction, developmental trajectory into the 20s, and why late maturation may be adaptive but also problematic in adolescence.

    • Frontal lobes occupy ~1/3 of cortex; prefrontal cortex supports higher cognition, separate from primary motor areas.
    • Executive function = planning, organizing, goal-directed behavior, resisting automatic impulses (cognitive control).
    • Frontal dysfunction is common in sleep deprivation, stress, and normal aging—not just overt brain injury.
    • Full frontal maturation extends into early–mid 20s; late development may allow exploration and flexible problem-solving.
    • Frontal subregions differ: lateral prefrontal (executive) vs. orbitofrontal (social/emotional).
  3. 26:20 – 40:00

    Rules, Context, and the Marshmallow Test: How Prefrontal Cortex Works

    They unpack how the frontal cortex stores and applies rules in a hierarchical fashion, using clinical anecdotes and classic experiments. D’Esposito describes patients who know social rules but can’t inhibit inappropriate actions, and they discuss the marshmallow test and training long-term goal maintenance.

    • Frontal patients often violate social rules (answering a doctor’s phone, jumping into a bed) despite knowing it’s wrong.
    • Problem is not loss of rules but failure to apply them in context due to impaired cognitive control.
    • Rules are stored in a hierarchy—from concrete (don’t kick the ball) to abstract (long-term health, sportsmanship).
    • Marshmallow task illustrates early individual differences in delaying gratification and maintaining longer-term goals.
    • Strategies can be taught to extend temporal horizons of goals (looking beyond immediate rewards).
  4. 40:00 – 53:20

    Can Cognitive Strategies Generalize? Goal Management and Training the Brain

    D’Esposito explains why early cognitive training often failed to generalize beyond the trained task and how therapies like goal management training attempt to bridge that gap. They discuss structured, therapist-led approaches that help patients become better at ‘doing things’ across domains.

    • Standard cognitive training often improves only the specific task practiced (poor far transfer).
    • Goal management training uses real-life projects (planning a meal, vacation, podcast) to teach planning, sub-goals, monitoring, and dealing with procrastination/anxiety.
    • When intensive and therapist-driven over weeks, patients report broad improvements in daily functioning.
    • D’Esposito is optimistic that well-designed cognitive therapies can truly generalize, but they are resource-intensive.
  5. 53:20 – 1:03:20

    Frontal Cortex, Limbic System, and Emotional Control

    The conversation explores how prefrontal and limbic/paralimbic regions interact to shape emotion, decision making, and adaptability. They contrast executive versus emotional/social frontal regions and emphasize that real-life decisions emerge from their dynamic interplay.

    • Frontal lobes include both executive (lateral PFC) and emotional/social (orbitofrontal, paralimbic) systems.
    • Damage can selectively impair social/emotional behavior while leaving executive skills intact, and vice versa.
    • Emotion and context powerfully modulate executive performance (e.g., worse decisions under stress or social discomfort).
    • Healthy cognition relies on flexible adaptation when routines break down, not just rigid adherence to plans.
  6. 1:03:20 – 1:11:40

    Smartphones, Social Media, and the Cost to Executive Function

    They assess how smartphones and social media relate to frontal rules and habits. D’Esposito notes that phones don’t make him better at emergency decision-making, and both worry that modern devices train shallow, non-transferable algorithms that may erode navigational skills and deep focus.

    • Smartphones enable rapid, shallow task switching across many contexts, unlike deep, linear tasks (e.g., reading).
    • D’Esposito finds no benefit from his phone in acute medical reasoning; it only helps retrieve factual information (drug doses).
    • Overreliance on GPS may erode problem-solving and spatial skills once learned through maps and exploration.
    • He suspects heavy smartphone use may harm, or at least fail to support, frontal-lobe development and function.
  7. 1:11:40 – 1:20:00

    Working Memory: Definition, Circuits, and Why It Underpins Cognition

    D’Esposito defines working memory as the ability to hold and manipulate information briefly and explains its neural basis in sustained prefrontal activity and interactions with sensory cortices. They emphasize its role as foundational for reading, reasoning, and executive control.

    • Working memory maintains information no longer present (digits, social security numbers, mental images).
    • It is active, not passive—supports mental math, visual search, and complex reasoning.
    • Prefrontal neurons show persistent activity during working memory; PFC keeps task-relevant sensory areas active.
    • There is no single ‘buffer’; the whole brain acts as a distributed buffer controlled by PFC.
    • Working memory is critical for reading comprehension, planning, and almost every higher cognitive function.
  8. 1:20:00 – 1:35:00

    Dopamine and the Inverted-U: When Enhancement Helps or Hurts

    They dive into dopamine’s role in working memory and the classic finding that both dopamine depletion and excess are harmful. D’Esposito explains his bromocriptine studies, the use of PET and COMT genotyping, and why pharmaceutical companies have largely ignored cognition-enhancing drugs.

    • Dopamine from brainstem nuclei projects to basal ganglia (movement) and prefrontal cortex (working memory).
    • Depleting dopamine impairs working memory; restoring it improves performance in animals and humans.
    • Bromocriptine (D2 agonist) improved working memory in low-dopamine individuals but worsened it in high-dopamine ones.
    • Working memory capacity (digit span) strongly correlates with frontal dopamine levels measured by PET.
    • COMT polymorphisms affect dopamine breakdown in PFC; slow COMT = higher dopamine; fast COMT = lower.
    • Despite strong science, pharma has not pursued cognition-focused dopamine or multimodal neuromodulator drugs.
  9. 1:35:00 – 1:45:00

    Stimulants, Nootropics, and the Ethics of Cognitive Enhancement

    Huberman and D’Esposito discuss off-label stimulant use (Adderall, Ritalin, modafinil) and supplements, highlighting the danger of assuming ‘more catecholamines is better.’ D’Esposito favors targeted neuromodulation (e.g., bromocriptine, guanfacine) tailored to individual neurochemistry over broad-spectrum stimulants.

    • Adderall/Ritalin increase multiple catecholamines (dopamine, norepinephrine) non-selectively; precision is poor.
    • Bromocriptine at low doses produces no ‘buzz’—participants can’t distinguish drug from placebo yet show cognitive gains.
    • Guanfacine (a blood pressure medication affecting norepinephrine) shows promise in post-COVID brain fog and working memory.
    • D’Esposito cautions that high-functioning students given dopaminergic drugs often get worse on working memory tasks.
    • He argues enhancement should aim for optimization, not supranormal ‘superhuman’ states, and must be individualized.
  10. 1:45:00 – 2:08:20

    Concussion and Traumatic Brain Injury: Axons, Frontal Networks, and Recovery

    They unpack what concussion actually is—diffuse axonal injury from rapid brain movement—and why frontal regions are particularly vulnerable. D’Esposito describes persistent post-concussion syndrome, the mismatch between clinical dogma and patient reality, and emerging rehab strategies.

    • Concussion/mild TBI = tearing/stretching of axons, especially in frontal white matter, even without loss of consciousness.
    • Longer loss of consciousness and symptoms generally indicate more extensive axonal damage.
    • Many people still have cognitive fog, light sensitivity, dizziness, and sleep disruption a year later.
    • Frontal axon damage causes subtle but impactful executive deficits (e.g., 1–10% drops can matter greatly).
    • Old advice of prolonged rest in dark rooms is shifting toward early, graded physical and cognitive activity as tolerated.
    • Cognitive tools (e.g., BrainHQ) may help, but access and quality control are major barriers.
  11. 2:08:20 – 2:23:20

    Use It or Lose It: Aging, Reading, and Everyday Cognitive Training

    They explore whether executive and working memory circuits follow a ‘use it or lose it’ trajectory and how daily habits influence brain aging. D’Esposito encourages reading, complex intellectual engagement, and structured life planning as real-world executive training.

    • Frontal/executive systems decline more with age than many other brain systems; small declines can matter.
    • Beyond preventing dementia, goal should be optimizing brain health and function across the lifespan.
    • Professionals juggling teaching, research, and clinical work naturally stress-test executive function; many others do not.
    • Consciously adding fiction and non-fiction reading, learning new domains (history, literature), and rich hobbies can build cognitive reserve.
    • Simple metrics of brain health are lacking in primary care; D’Esposito calls for standardized brain health indices.
  12. 2:23:20 – 2:40:00

    Alzheimer’s, Parkinson’s, Nicotine, and Hormones in Cognition

    The discussion shifts to neurodegenerative diseases. D’Esposito explains why Alzheimer’s has resisted simple neurotransmitter-based treatments, the limited utility of current cholinesterase inhibitors, and the more successful dopamine-based treatment of Parkinson’s. They also touch on nicotine, estrogen, and sex differences in frontal dopamine.

    • Alzheimer’s involves plaques, tangles, and multiple pathologies; acetylcholine deficits exist but are not primary drivers.
    • Cholinesterase inhibitors (e.g., donepezil) offer modest symptomatic benefit but don’t alter disease course.
    • Parkinson’s (dopamine degeneration) is more amenable to L-DOPA and dopamine agonists because of a clearer single-transmitter deficit.
    • Some data suggest nicotine (cholinergic agonist) can transiently boost attention/memory, but evidence for long-term protection is weak and delivery routes (smoking, vaping) are harmful.
    • Prefrontal cortex is rich in estrogen receptors; estrogen boosts dopamine there, modulating working memory across the menstrual cycle (high estrogen = higher dopamine and better PFC function, especially in low-baseline individuals).
    • Optimizing hormonal milieu (for both sexes) may be important for cognitive health but is understudied.
  13. 2:40:00 – 2:53:20

    Mindfulness, Exercise, and Network Neuroscience: New Frontiers in Brain Optimization

    They discuss mindfulness as an executive skill-building tool, aerobic exercise as a robust enhancer of executive function, and the emerging science of brain networks and modularity. D’Esposito describes how network measures predict who benefits from interventions and his vision for simple brain-state biomarkers.

    • Mindfulness practices (focus on breath, noticing distraction, refocusing) improve the ‘stop, relax, refocus’ capacity crucial for executive function.
    • Aerobic exercise, in some studies, matches or exceeds structured cognitive training for boosting executive function.
    • Brain network modularity—degree of functional segregation between networks—is a powerful predictor of cognitive performance and response to therapy.
    • Higher baseline modularity predicted greater gains from goal management training in TBI patients and other interventions.
    • Moment-to-moment changes in modularity correlate with perceptual performance (e.g., detecting faint sounds).
    • D’Esposito is collaborating with groups to derive physiological proxies (e.g., HRV, oxygenation) that could track brain state non-invasively, analogous to sleep trackers.
  14. 2:53:20

    Reframing Neurology: From Disease-Centric to Brain Health Optimization

    In closing, Huberman and D’Esposito reflect on neurology’s historically descriptive, disease-centric focus and the need for a preventative, optimization-oriented paradigm. D’Esposito argues that patients must advocate for themselves and that future medicine will combine network biomarkers with multi-modal interventions to personalize brain health.

    • Neurologists historically excel at description but lack tools to improve everyday brain health; this is changing.
    • Primary care exams still almost entirely ignore brain health beyond casual conversation.
    • Brain health indices (e.g., UT Dallas’s Brain Health Project) aim to quantify cognition, lifestyle, social connection, and well-being.
    • Patients increasingly must self-educate and advocate for access to emerging therapies.
    • D’Esposito is optimistic that neuroscience discoveries are finally translating into tools that will help people optimize cognition, not merely treat late-stage disease.

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.